State Street Corp Belite Bio, Inc Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Belite Bio, Inc stock. As of the latest transaction made, State Street Corp holds 20,203 shares of BLTE stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,203
Previous 20,098
0.52%
Holding current value
$1.49 Million
Previous $1.33 Million
12.41%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BLTE
# of Institutions
18Shares Held
76.3KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA12.9KShares$945,8890.0% of portfolio
-
Marshall Wace, LLP London, X09.49KShares$697,5050.0% of portfolio
-
Jpmorgan Chase & CO New York, NY8.16KShares$600,1510.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.46KShares$548,2390.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.3KShares$316,1790.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.83B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...